Development of a therapy against metastatic bladder cancer using an interleukin-2 surface-modified MB49 bladder cancer stem cells vaccine

INTRODUCTION: In previous study the streptavidin interleukin-2 (SA-IL-2)-modified MB49 vaccine was effective against bladder cancer in a mouse model. However, a small portion of tumors regrew because the vaccine could not eliminate MB49 bladder cancer stem cells (MCSCs). Accordingly, we developed a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yong-tong, Pang, Shi-yu, Lei, Cheng-yong, Luo, Yang, Chu, Qing-jun, Tan, Wan-long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4644293/
https://www.ncbi.nlm.nih.gov/pubmed/26566931
http://dx.doi.org/10.1186/s13287-015-0211-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4644293/
https://www.ncbi.nlm.nih.gov/pubmed/26566931
http://dx.doi.org/10.1186/s13287-015-0211-1

Ejemplares similares